- Home
- »
- Nutraceuticals & Functional Foods
- »
-
Europe Gut Health Supplements Market Size Report, 2033GVR Report cover
Europe Gut Health Supplements Market (2026 - 2033)
Size, Share & Trends Analysis Report By Product (Probiotic Supplements, Prebiotic Supplements), By Form (Capsules, Tablets, Soft Gels), By Distribution Channel (OTC, Prescribed), By Country, And Segment Forecasts
Market Size, 2025
$4.2BMarket Estimate, 2026
$4.5BMarket Forecast, 2033
$7.3BCAGR, 2026–2033
7.1%Europe Gut Health Supplements Market Summary
The Europe gut health supplements market size was valued at USD 4.2 billion in 2025 and is projected to grow from USD 4.5 billion in 2026 to USD 7.3 billion by 2033, at a CAGR of 7.1% from 2026 to 2033. The market is supported by increasing consumer awareness of the relationship between gut health, immunity, digestion, and overall wellness.
Key Market Trends & Insights
- By product: Probiotic gut health supplements segment accounted for the largest share of 41.9% of the revenue in 2025.
- By form: Capsules segment held a 43.1% market share in 2025.
- By distribution channel: Sales through OTC channels held a 77.7% market share in 2025.
Market Size & Forecast
- Market size in 2025: USD 4.2 Billion
- Estimated market size in 2026: USD 4.5 Billion
- Projected market size by 2033: USD 7.3 Billion
- CAGR (2026-2033): 7.1%
Prism AI by Grand View Research Free to tryAsk a question about the europe gut health supplements marketTry asking✓Every figure cited from GVR research Prefer the report? Download free sample →The Europe gut health supplements industry is being shaped by growing consumer awareness of the connection between digestive health and broader well-being. Consumers are increasingly incorporating gut health products into daily wellness routines to support digestion, bowel regularity, microbiome balance, immunity, and overall health. Rising interest in preventive healthcare and self-care is encouraging demand for convenient supplementation alongside healthy diets and active lifestyles.
Source: Grand View Research, IR Documents, Primary Interviews, Paid DatabasesTo learn more about this report,Download Free Sample Report
A key market trend is the shift toward science-backed and targeted gut health solutions. Consumers are becoming more attentive to ingredient quality, formulation transparency, clinical evidence, and specific health benefits when selecting products. This is encouraging manufacturers to develop probiotic, prebiotic, synbiotic, postbiotic, fiber, and digestive enzyme formulations designed around particular consumer needs. Clean-label, plant-based, allergen-conscious, and minimally processed formulations are also gaining attention as consumers increasingly connect gut health with broader nutrition and wellness preferences.
Product innovation is further expanding the category. In May 2026, Probi launched Rham271h at Vitafoods Europe, its first postbiotic solution, based on a heat-inactivated Lacticaseibacillus rhamnosus strain. The ingredient was developed to provide greater formulation flexibility and stability compared with live probiotic cultures, supporting applications across different product formats. The launch reflects increasing industry interest in next-generation microbiome ingredients and demonstrates how suppliers are responding to demand for stable, scientifically developed gut health solutions.
Another important trend is the personalization of gut health supplementation. Brands are increasingly developing products targeted toward areas such as digestive comfort, women's health, immunity, stress management, healthy aging, and metabolic wellness. At the same time, delivery formats are evolving beyond traditional capsules and tablets, with gummies, powders, sachets, chewables, and functional beverages improving convenience and encouraging regular consumption.
Digital commerce and health-focused retail channels are also influencing purchasing behavior by giving consumers greater access to specialized products, ingredient information, reviews, and educational content. Overall, the market is moving toward targeted, convenient, transparent, and evidence-led gut health solutions, creating opportunities for brands that can combine credible science with consumer-friendly formulations and clear product positioning.
Market Dynamics
The Europe market is benefiting from growing consumer focus on digestive wellness, immunity, and preventive healthcare. Increasing awareness of the gut-health connection, digestive disorders, lifestyle-related concerns, and antibiotic use is supporting demand for probiotics, prebiotics, and fiber-based products. Probiotics remain the leading product category in Europe, reflecting established consumer awareness and broad market availability. In May 2025, Lab4 Probiotics officially launched at Vitafoods Europe in Barcelona, highlighting its research-backed probiotic blends and clinical evidence across multiple health applications. The launch demonstrates how brands are leveraging scientific substantiation and targeted probiotic formulations to strengthen consumer confidence and differentiate products in the European market.
Regulatory complexity remains a key restraint for the Europe market, as manufacturers must comply with requirements covering product composition, safety, labeling, and health claims. Regulation (EC) No. 1924/2006 requires that nutrition and health claims used in product labeling and advertising be clear, scientifically substantiated, and non-misleading, thereby increasing the evidence requirements for products positioned around digestive and microbiome benefits. In addition, ingredients that qualify as Novel Foods under Regulation (EU) 2015/2283 may require authorization before being placed on the Europe market. Food supplements are also subject to Directive 2002/46/EC, which establishes Europe-level requirements for vitamins and minerals used in supplements, while individual member states may impose additional notification requirements. These requirements can increase compliance costs, lengthen product-development timelines, and create additional complexity for companies seeking pan-European market expansion.
A significant opportunity for the Europe market lies in the development of postbiotics and other next-generation microbiome solutions. Unlike live probiotics, postbiotics can offer greater stability during processing and storage, broader compatibility with formulations, and reduced viability-related constraints. This creates opportunities for manufacturers to develop stable, targeted, and convenient gut-health products across supplements, functional foods, and beverages. Postbiotic supplements are also projected to be the fastest-growing product segment in the European market, highlighting their increasing commercial potential.
Analyst Perspective
The European market for gut health supplements is primarily driven by rising consumer awareness of the link between digestive health and overall well-being, including immunity, mood, and metabolism. The increasing prevalence of digestive disorders, lifestyle-related gut issues, and antibiotic usage has boosted demand for probiotics, prebiotics, and fiber-based products. In addition, the growing trend toward preventive healthcare, clean-label and plant-based formulations, and personalized nutrition influences purchasing behavior. Innovation in delivery formats such as gummies, powders, and functional beverages, along with scientific backing and regulatory approval of probiotic strains, further supports regional market growth.
Consumer Insights for Europe Gut Health Supplements Market
Consumers in Europe are increasingly incorporating gut health supplements into preventive wellness and daily nutrition routines, with purchasing decisions influenced by digestive comfort, microbiome balance, immunity, and overall well-being. Probiotics remain widely recognized, while interest is expanding toward prebiotics, synbiotics, postbiotics, and fiber-based formulations. Consumers increasingly favor clean-label ingredients, clinically supported formulations, transparent labeling, and convenient formats such as capsules, powders, gummies, and functional drinks. E-commerce and pharmacy channels also facilitate product discovery and comparison. Personal health goals, recommendations from healthcare professionals, online information, and brand credibility further influence purchase decisions, while perceived efficacy supports repeat consumption.
To learn more about this report,Download Free Sample Report
Product Insights
The probiotic gut health supplements segment accounted for the largest share of 41.9% of the revenue in 2025. In Europe, the market is benefiting from rising consumer awareness of gut health, preventive wellness, and the broader role of the microbiome in overall health. Demand is increasingly supported by interest in digestive wellness, immunity, and condition-specific solutions, alongside growing preference for natural, vegan, organic, and clean-label formulations. In February 2025, The Gut Health Doctor launched Smart Strains, a range of four condition-specific probiotic supplements backed by international health guidelines, demonstrating the market’s shift toward targeted and evidence-led probiotic products.
To learn more about this report,Download Free Sample Report
The postbiotic gut health supplements segment is projected to grow at a CAGR of 11.7% from 2026 to 2033. The postbiotic supplements segment is gaining momentum as consumers and manufacturers increasingly seek stable, science-backed alternatives to live probiotic formulations. As postbiotics contain non-living microbial preparations, they can offer greater stability during processing, storage, and distribution, while providing greater flexibility across supplement, food, and beverage formats. This supports their adoption in targeted gut and immune-health applications. Growing consumer interest in microbiome health and evidence-based wellness is further driving demand for postbiotic solutions focused on gut-barrier support, immune modulation, and digestive wellness.
Form Insights
The capsules segment held a 43.1% market share in 2025. Capsules are a widely adopted delivery format in the European market, offering convenient dosing, portability, and formulation flexibility across probiotics, prebiotics, synbiotics, digestive enzymes, and postbiotics. Advanced capsule technologies, including delayed-release and enteric coatings, can help protect sensitive ingredients from gastric conditions and support delivery to the intestine. Plant-based and gelatin-free shells also align with growing demand for vegan and clean-label products.
To learn more about this report,Download Free Sample Report
Gummies/ Chew are projected to register a 9.0% CAGR from 2026 to 2033. The European gut health gummies and chewables segment is expanding as consumers increasingly favor convenient and enjoyable alternatives to traditional pills. Product development is shifting toward multi-biotic formulations that combine probiotics, prebiotics, and postbiotics, alongside sugar-free, plant-based, naturally flavored, and stability-enhanced solutions. In May 2025, TopGum launched Gummiotics at Vitafoods Europe, a chewable gut-health supplement combining probiotics, prebiotics, and the postbiotic BPL1. The sugar-free product uses Bacillus subtilis, prebiotic fiber, and BPL1 and is offered in natural orange and strawberry flavors. The launch highlights the segment’s move toward convenient, multifunctional, clean-label, and formulation-stable gut health products.
Distribution Channel Insights
The sales through OTC channels held a 77.7% market share in 2025. Consumers are increasingly choosing over-the-counter (OTC) gut health supplements in Europe due to their convenience and accessibility. These products are widely available in pharmacies, health stores, and online platforms, allowing consumers to manage their digestive and overall wellness without needing a prescription. The rise in awareness of preventive healthcare has also encouraged individuals to take control of their gut health, as it is closely linked to immunity, mental well-being, and overall health.
To learn more about this report,Download Free Sample Report
The prescribed gut health supplements segment is projected to grow at a CAGR of 6.2% from 2026 to 2033, supported by the rising burden of gastrointestinal disorders and increasing clinical interest in microbiome-based interventions. Greater evidence supporting specific probiotic strains and targeted formulations is strengthening healthcare professionals’ confidence in recommending specialized products. Demand is further supported by the use of gut-health supplements alongside conventional treatments and expanding access through hospitals, specialist clinics, and pharmacies. As personalized, condition-specific digestive health management gains traction, prescribed formulations are expected to meet growing demand among patients requiring more targeted interventions.
Regional Insights
The gut health supplements industry in Europe is evolving from a traditional digestive-care category into a broader microbiome and preventive-wellness market. Consumers are increasingly linking gut health to immunity, energy, metabolic health, and overall well-being, driving demand for products that deliver benefits beyond basic digestive support. This is encouraging brands to diversify portfolios across probiotics, prebiotics, synbiotics, postbiotics, fiber, and digestive enzymes.
Italy Gut Health Supplements Market Trends
The Italy gut health supplements industry accounted for a share of 32.2% of the revenue in 2025. Italy represents a strong market for gut health supplements, supported by high supplement adoption, widespread pharmacy distribution, and growing consumer attention to digestive wellness. Digestive complaints such as bloating, reflux, constipation, abdominal discomfort create demand for probiotics, digestive-support products, and natural formulations. The market also benefits from Italy’s strong preference for botanical and evidence-based wellness solutions, creating opportunities for products positioned around microbiome balance and digestive comfort.
The gut health supplements industry in Germany is expected to grow at the fastest CAGR of 8.4% during the forecast period. Germany’s market is benefiting from growing awareness of preventive health, interest in the gut microbiome, and demand for science-backed digestive solutions. Consumers are increasingly seeking targeted formulations that address everyday factors such as stress, diet, and medication-related digestive concerns. In June 2025, Weber & Weber launched Innovall DAILY biotic+ in German pharmacies, combining 11 probiotic strains with guar-bean fiber, cocoa-bean polyphenols, and vitamins B2 and B6. The launch highlights Germany’s growing focus on multi-ingredient, pharmacy-led, and microbiome-oriented formulations.
Key Europe Gut Health Supplements Company Insights
The Europe gut health supplements market is moderately fragmented, with competition spanning multinational healthcare companies, established probiotic brands, and emerging microbiome-focused players. Market positioning is shaped by clinical evidence, ingredient quality, brand credibility, product innovation, and distribution reach. Companies increasingly compete through targeted formulations, clean-label ingredients, and convenient delivery formats.
To learn more about this report,Download Free Sample Report
Key Europe Gut Health Supplements Companies
-
Nestlé Health Science
-
Bayer AG
-
Amway Corp.
-
Herbalife International, Inc
-
Ritual
-
Seed Health, Inc.
-
Nature's Sunshine Products, Inc.
-
NOW Foods
-
BioGaia
-
RenewLife
-
Nutrafol
Competitive Benchmarking
Category
Operating Strategies
Competitive Edge
Weakness
Established Players (Nestlé Health Science; Bayer AG; Amway Corp.; Herbalife International, Inc.; NOW Foods; Nature’s Sunshine Products, Inc.; BioGaia)
Broad supplement portfolios, extensive distribution networks, and continued investment in probiotics, digestive health, and wellness formulations.
Strong brand recognition, established retail/pharmacy access, broad product portfolios, and formulation capabilities.
Broad portfolios can reduce specialization in niche microbiome segments and may increase complexity in product differentiation.
Emerging Players (Seed Health, Inc.; Ritual; RenewLife)
Focus on targeted gut-health solutions, microbiome-focused formulations, convenient delivery formats, and digitally supported consumer engagement.
Specialized positioning, targeted formulations, strong direct-to-consumer capabilities, and faster product innovation.
Comparatively narrower portfolios and distribution reach across European markets, with greater dependence on specific product categories.
Recent Developments
-
In July 2025, Height’s brand focused on brain and gut health, launched a new hydration supplement enhanced with citicoline (Cognizin) aimed at everyday active consumers rather than elite athletes. The product delivers electrolytes plus a cognitive support ingredient to help maintain mental energy and focus. It will be offered in three cocktail-inspired flavors peach spritz, lime margarita, and mango ginger mule.
-
In June 2025, SUANNUTRA entered an exclusive distribution agreement with UK-based Myota to bring next-generation prebiotic fibre blends to the U.S., UK, and Europe markets. The partnership included Myota’s Metabolic Regulator blend, a nine-fibre formula engineered to survive stomach acid and ferment selectively in the colon. The blend had been clinically validated to support metabolic health: improving blood sugar control, lowering LDL cholesterol, regulating appetite hormones, and reducing inflammation.
Europe Gut Health Supplements Market Report Scope
Report Attribute
Details
Market size in 2025
USD 4.2 billion
Estimated market size in 2026
USD 4.5 billion
Projected market size by 2033
USD 7.3 billion
Growth rate (Revenue)
CAGR of 7.1% from 2026 to 2033
Actuals
2021 - 2025
Forecast period
2026 - 2033
Quantitative (Revenue) units
Revenue in USD billion and CAGR from 2026 to 2033
Report coverage
Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered
Product, form, distribution channel, country
Country scope
UK; Germany; France; Italy; Spain
Key companies profiled
Nutrafol; Nestlé Health Science; Bayer AG; Amway Corp.; Herbalife International, Inc.; NOW Foods; Nature's Sunshine Products, Inc.; BioGaia; Seed Health, Inc.; Ritual; RenewLife
Customization scope
Free report customization (equivalent up to 8 analysts’ working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options
Avail customized purchase options to meet your exact research needs. Explore purchase options
Europe Gut Health Supplements Market Report Segmentation
This report forecasts revenue growth at the regional and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the Europe gut health supplements market report based on product, form, distribution channel, and country.
-
Product Outlook (Revenue, USD Billion, 2021 - 2033)
-
Probiotic Supplements
-
Prebiotic Supplements
-
Synbiotic Supplements
-
Postbiotic Supplements
-
Digestive Enzyme Supplements
-
Fiber Supplements
-
Detox/Cleanse Supplements
-
Greens Supplements
-
Other Gut Health Supplements
-
-
Form Outlook (Revenue, USD Billion, 2021 - 2033)
-
Capsules
-
Tablets
-
Soft Gels
-
Powders
-
Liquids
-
Gummies/ Chews
-
Others
-
-
Distribution Channel Outlook (Revenue, USD Billion, 2021 - 2033)
-
OTC
-
Supermarkets/ Hypermarkets/Food Stores
-
Drug Stores & Pharmacies
-
Convenience Stores
-
Online
-
Others
-
-
Prescribed
-
-
Country Outlook (Revenue, USD Billion, 2021 - 2033)
-
UK
-
Germany
-
France
-
Italy
-
Spain
-
Research Methodology
The Europe gut health supplements market figures in this report are based on a proven research process that combines executive interviews with secondary research from proprietary databases, company filings, and recognized regulatory and institutional sources. Market size is built through value-chain sizing-reconciling supply-side and demand-side estimates-and triangulated with bottom-up and top-down approaches. Every estimate passes multiple levels of expert validation before publication, with each Europe gut health supplements segment quantified using the revenue-capture definitions in the table below.
Segment Definition
Segment - Ingredient Type
Revenue capture definition
Probiotic Supplements
This segment includes the sales of supplements containing live microorganisms, such as beneficial bacteria and yeasts, formulated to support the balance and functioning of the gut microbiome. Products are commonly marketed for digestive health, regularity, and overall gastrointestinal wellness.
Prebiotic Supplements
This segment includes the sales of supplements containing nondigestible fibers or compounds that selectively support beneficial gut microorganisms. These products are primarily positioned to promote healthy gut bacteria, digestive function, and microbiome balance.
Synbiotic Supplements
This segment includes the sales of supplements that combine probiotics and prebiotics in a single formulation. The combination is designed to provide beneficial microorganisms while supplying substrates that support their survival, activity, and growth in the gastrointestinal tract.
Postbiotic Supplements
This segment includes the sales of supplements containing inactivated microorganisms, microbial components, or metabolites produced by microorganisms that are intended to provide health benefits. These products are positioned around supporting gut and digestive health without requiring live microorganisms.
Digestive Enzyme Supplements
This segment includes the sales of supplements containing digestive enzymes, such as amylase, protease, lipase, lactase, and other enzyme blends, designed to assist in the breakdown and digestion of carbohydrates, proteins, fats, and other food components.
Fiber Supplements
This segment includes the sales of supplements providing concentrated sources of dietary fiber, including soluble, insoluble, and functional fibers. These products are primarily used to support digestive regularity, bowel health, and overall gastrointestinal function.
Detox/Cleanse Supplements
This segment includes the sales of supplements marketed to support digestive cleansing, bowel regularity, or the removal of unwanted substances from the body. Formulations may contain herbal extracts, fibers, laxative botanicals, or other ingredients positioned for short-term cleansing and digestive wellness.
Greens Supplements
This segment includes the sales of supplements formulated with concentrated blends of vegetables, leafy greens, fruits, algae, grasses, and plant-based ingredients. These products are generally positioned as convenient sources of plant nutrients and are increasingly associated with digestive, nutritional, and overall wellness benefits.
Other Gut Health Supplements
This segment includes the sales of gut-health products formulations containing specialized nutrients, botanicals, fermented ingredients, or other compounds positioned to support digestive and gastrointestinal wellness.
Estimation Model
Layer
Key Question
Description
Consumption Profile Layer
Who consumes gut health supplements?
Captures consumers purchasing gut health supplements to support digestion, gut microbiome balance, regularity, and overall wellness.
Market Reach Layer
Where are gut health supplements accessible?
Covers pharmacies, supermarkets, health stores, and e-commerce platforms across Europe.
Purchase & Retention Layer
What drives repeat purchases?
Perceived efficacy, trusted brands, clinically supported ingredients, product quality, and convenience encourage repeat use.
Value Generation Layer
How is revenue generated
Revenue comes from probiotic, prebiotic, synbiotic, postbiotic, fiber, digestive enzyme, greens, detox/cleanse, and other gut-health supplements across capsules, powders, gummies, tablets, and liquid formats.
Delivered Customizations
This report has been delivered with the following In-depth customizations
Client Request
Customization Delivered
Value Adds
Europe Gut Health Supplements Market Landscape Assessment
Assessed product segments, key ingredients, consumer trends, competitive intensity, distribution channels, and market growth drivers across major European countries.
Helps identify high-growth segments, assess market attractiveness, and support informed market-entry and expansion strategies.
Europe Gut Health Supplements Regulatory & Product Assessment
Reviewed EU regulatory requirements, health-claim restrictions, product formulations, labeling requirements, and compliance considerations across probiotic, prebiotic, postbiotic, and other gut-health supplements.
Supports regulatory risk assessment, strengthens product-development planning, and helps companies navigate complex European compliance requirements.
Europe Gut Health Supplements Channel & Retail Assessment
Assessed pharmacies, supermarkets/hypermarkets, specialty health stores, e-commerce platforms, and direct-to-consumer channels to evaluate product accessibility and purchasing patterns.
Helps identify effective routes to market, prioritize high-potential channels, and evaluate opportunities to expand product distribution and consumer reach.
Frequently Asked Questions About This Report
The sales through OTC channels held a 77.7% market share in 2025, while prescribed gut health supplements segment is the fastest-growing distribution channel.
The Europe gut health supplements market size was valued at USD 4.2 billion in 2025 and is estimated at USD 4.5 billion in 2026.
The Europe gut health supplements market is expected to grow at a CAGR of 7.1% from 2025 to 2033 to reach USD 7.3 billion by 2033.
Key factors that are driving the market growth include rising health consciousness among consumers and shift from pharmaceutical to nutraceutical products
Probiotic gut health supplements segment accounted for the largest share of 41.9% of the revenue in 2025, while postbiotic supplements are the growing segment.
Some key players operating in Europe gut health supplements market include Nestlé Health Science, Bayer AG, Amway Corp., Herbalife International, Inc, NOW Foods, Nature's Sunshine Products, Inc., and others
The capsules segment held a 43.1% market share in 2025, while gummies/chew segment is the fastest-growing form.
About the Author(s)
Nutraceuticals & Functional Foods Research Team
Consumer Goods · Nutraceuticals & Functional FoodsThis report was authored by the nutraceuticals & functional foods research team at Grand View Research - comprising two research analysts, one senior research analyst, and one industry expert - with specialized expertise in the nutraceuticals & functional foods segment of the consumer goods industry. All findings are based on proprietary consumer goods databases, executive interviews, and regulatory analysis, subject to internal peer review prior to publication.
Last Updated:
Speak to Analyst
Customize this report to your needs - add regions, segments, or data points, with 20% free customization.
Or view our licence options:
ISO 9001:2015 & 27001:2022 Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.